Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer's dementia
Koushi Higashi; Tomohiro Sasaki; Hikari Takahashi; Yosuke Kawai; Stefanie Hennig; Koichi Shimizu; Masami Nakai; Kaneyoshi Takahashi; Yu NakamuraShow moreShow less
Office of Clinical Pharmacology, Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., 3-2-27 Otedori, Chuo-ku, Osaka, 540-0021, Japan; Office of Clinical Pharmacology, Headquarters of Clinical Development, Otsuka Pharmaceutical Co., Ltd., Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan; Certara Inc., Melbourne, VIC, Australia; Currently QuanTx Consulting, Mountain View, CA, USA; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd., Shinagawa Grand Central Tower, 2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan; Department of Medical Affairs, Otsuka Pharmaceutical Co., Ltd., 3-2-27 Otedori, Chuo-ku, Osaka, 540-0021, Japan; Department of Neuropsychiatry, Faculty of Medicine, Kagawa University, Kagawa, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, JapanShow moreShow less
Characterization of unusual pyrazole ring-rearranged metabolites of DS-1971a specific to monkeys
Daigo Asano; Kazuyoshi Michiba; Kayoko Masuda; Takashi Ohnuki; Makoto Suzuki; Tetsuya Suzuki; Hideyuki Shiozawa; Tsuyoshi Shinozuka; Toshio Takatsu; Daisuke NakaiShow moreShow less
Drug Metabolism and Pharmacokinetics Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories I, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Modality Research Laboratories II, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Discovery Science and Technology Department, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan; Analytical & Quality Evaluation Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Corporate Planning Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan; Center for Pharmaceutical and Biomedical Analysis, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, JapanShow moreShow less
Development of a method for vancomycin monitoring in interstitial fluid using a novel porous microneedle array patch
Jo Terauchi; Taisei Kawamura; Jongho Park; Kiyomi Saito; Masataka Tajima; Hitoshi Sato; Beomjoon Kim; Erika SugiyamaShow moreShow less
Department of Pharmacokinetics and Pharmacodynamics, Graduate School of Pharmacy, Showa Medical University, Tokyo, Japan, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan; Department of Precision Engineering, School of Engineering, The University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo, 113-8656, Japan; Institute of Industrial Science, The University of Tokyo, 4-6-1 Komaba, Meguro-ku, Tokyo, 153-8505, Japan; Innovation Center for Cannabinoid Research, Faculty of Pharmacy, Mahidol University, Bangkok, 10400, ThailandShow moreShow less
Development and validation of LC–MS-based bioanalytical methods for oligonucleotide therapeutics: points to consider
Yuchen Sun; Kosuke Saito; Shin-ichiro Nitta; Ryoya Goda; Yuki Kishino; Hisashi Fujita; Masaaki Kakehi; Yoshiharu Hayashi; Satoshi Ito; Tomomi Ishida; Kiyomi Kikuchi; Kazuko Inoue; Kazutaka Shimbo; Takeru Yamaguchi; Fumihiro Jinno; Kaori Murakoshi; Chie Murata; Kentaro Takahara; Mitsuhiko Kawabata; Ruri Kikura-Hanajiri; Yoshiro SaitoShow moreShow less
Division of Medicinal Safety Science, National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, Japan; Mediford Corporation, 1-15-10 Shimura, Itabashi-ku, Tokyo, 174-0056, Japan; Future Peak Co., Ltd., 3-48 Imainakamachi, Nakahara-ku, Kawasaki City, Kanagawa, 211-0065, Japan; Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo, 140-8710, Japan; Takeda Pharmaceutical Co., Ltd., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; CMIC Pharma Science Co., Ltd., 17-18 Nakahatacho, Nishiwaki City, Hyogo, 677-0032, Japan; Sekisui Medical Co., Ltd., 2117 Muramatsu, Tokai-mura naka-gun, Ibaraki, 319-1182, Japan; Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba, Ibaraki, 300-2635, Japan; Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki City, Kanagawa, 210-8681, Japan; Sumika Chemical Analysis Service, Ltd., 3-1-135 Kasugadenaka, Konohana-ku, Osaka City, Osaka, 554-0022, Japan; Axcelead Drug Discovery Partners, Inc., 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-0012, Japan; Tanabe Pharma Corporation, 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa, 251-8555, Japan; Ono Pharmaceutical Co., Ltd., 3-1-1 Sakurai, Shimamotocho, Mishima-gun, Osaka, 618-8585, Japan; Thermo Fisher Scientific K.K., 3-9 Moriyacho, Kanagawa-ku, Yokohama City, Kanagawa, 221-0022, Japan; Shin Nippon Biomedical Laboratories Ltd., 16-1 Minamiakasaka, Kainan-city, Wakayama, 642-0017, Japan; National Institute of Health Sciences, 3-25-26 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa, 210-9501, JapanShow moreShow less
A permeability assay adapted for the assessment of very poorly permeable compounds in the bRo5 space
Paulina Page; Dallas BednarczykShow moreShow less
Pharmacokinetic Sciences, Novartis Institutes of BioMedical Science, Cambridge, MA, USAShow moreShow less
Tyrosine kinase inhibitors suppress cytochrome P450 2C8 and 2J2 functions and their expression in renal cell carcinoma
Ayaka Kojima; Masayuki Nadai; Hiroshi Yamazaki; Miki KatohShow moreShow less
Laboratory of Pharmaceutics, Faculty of Pharmacy, Meijo University, Nagoya, Japan; Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, JapanShow moreShow less
FAQ
How long does Drug Metabolism and Pharmacokinetics take to review a manuscript?
As of 2026-11-19, CrushSCI has 12 complete review records for Drug Metabolism and Pharmacokinetics. The fastest paper went from submission to acceptance in 44 days (K2-EDTA anticoagulant suppresses calcium-dependent paraoxonase 1-mediated hydrolysis in human plasma stability assays, received 2026-03-06, accepted 2026-04-19); the slowest took 186 days. The average is 111 days and the median is 110 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
